Acarix AB (publ)
STO: ACARIX.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Aamir Mahmood
- Employees
- 8
- Headquarters
- Malmö, Sweden
- IPO year
- 2016
- Market cap
- SEK 296.6M
- Website
- https://www.acarix.com
Loading ACARIX…
Loading profile data…Frequently asked questions about ACARIX
What does Acarix AB (publ) (ACARIX.ST) do?
Acarix AB (publ), a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases in Germany, Sweden, the Middle East, Switzerland, Austria, and internationally. The company offers CADScor System, a non-invasive and ultra-sensitive analytical device for the diagnosis of coronary artery disease. Acarix AB (p...
Where does ACARIX.ST trade?
Acarix AB (publ) (ACARIX.ST) trades on the Stockholm Stock Exchange.
What sector is ACARIX.ST in?
Acarix AB (publ) (ACARIX.ST) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Acarix AB (publ)?
Aamir Mahmood is the chief executive officer of Acarix AB (publ) (ACARIX.ST).
Where is Acarix AB (publ) headquartered?
Acarix AB (publ) is headquartered in Sweden.
Does ACARIX.ST pay a dividend?
Acarix AB (publ) (ACARIX.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ACARIX.ST go public?
Acarix AB (publ) (ACARIX.ST) completed its initial public offering in 2016.